{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:27:22Z","timestamp":1789964842587,"version":"4.0.1"},"reference-count":28,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,4,1]]},"abstract":"<jats:p>B-cell chronic lymphocytic leukemia (B-CLL) is a heterogenous disease with a highly variable clinical course. Recent studies have shown that CD38 surface expression on the malignant cell clone may serve as a prognostic marker in that CD38+ patients with B-CLL are characterized by advanced disease stage, lesser responsiveness to chemotherapy, and shorter survival than CD38\u2212 patients. To further investigate the molecular phenotype of these 2 clinical subgroups, we compared the gene expression profiles of CD38+ (n\u2009=\u200925) with CD38\u2212 (n\u2009=\u200945) B-CLL patients using oligonucleotide-based DNA chip microarrays representative of approximately 5600 genes. The results showed that B-CLLs display a common gene expression profile that is largely independent of CD38 expression. Nonetheless, the expression of 14 genes differed significantly between the 2 groups, including genes that are involved in the regulation of cell survival. Furthermore, unsupervised hierarchical cluster analysis of 76 B-CLL samples led to the separation of 2 major subgroups, comprising 20 and 56 patients. Clustering to the smaller group was due in part to the coordinate high expression of a large number of ribosomal and other translation-associated genes, including elongation factors. Importantly, we found that patients with high expression of translation factors were characterized by a more favorable clinical course with significantly longer progression-free survival and reduced chemotherapy requirements than the remaining patients (P\u2009&lt;\u2009.05). Our data show that gene expression profiling can help identify B-CLL subtypes with different clinical characteristics. Furthermore, our results suggest a role of translation-associated genes in the pathogenesis of B-CLL.<\/jats:p>","DOI":"10.1182\/blood-2002-09-2683","type":"journal-article","created":{"date-parts":[[2003,3,17]],"date-time":"2003-03-17T20:22:55Z","timestamp":1047932575000},"page":"2748-2755","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":69,"title":["Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia"],"prefix":"10.1182","volume":"101","author":[{"given":"Jan","family":"Du\u0308rig","sequence":"first","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Nu\u0308ckel","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hu\u0308ttmann","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Kruse","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Ho\u0308lter","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Halfmeyer","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Fu\u0308hrer","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Rudolph","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Kalhori","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnd","family":"Nusch","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Deaglio","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Malavasi","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Mo\u0308ro\u0308y","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Klein-Hitpass","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Du\u0308hrsen","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, the Institute for Medical Informatics, Biometry and Epidemiology, and the Institute of Cell Biology, Medical Faculty, University of Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Essen; Gemeinschaftspraxis fu\u0308r Ha\u0308matologie und Onkologie Velbert, Germany; and the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111823182252100_B1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.bloodjournal462219","article-title":"Clinical staging of chronic lymphocytic leukemia.","volume":"46","author":"Rai","year":"1975","journal-title":"Blood."},{"key":"2019111823182252100_B2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer."},{"key":"2019111823182252100_B3","first-page":"96","article-title":"Prognostic factors in chronic lymphocytic leukaemia.","volume":"84","author":"Binet","year":"1999","journal-title":"Haematologica."},{"key":"2019111823182252100_B4","first-page":"42","article-title":"Chronic lymphocytic leukemia: staging and prognostic factors.","volume":"25","author":"Zwiebel","year":"1998","journal-title":"Semin Oncol."},{"key":"2019111823182252100_B5","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.","volume":"94","author":"Damle","year":"1999","journal-title":"Blood."},{"key":"2019111823182252100_B6","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood."},{"key":"2019111823182252100_B7","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.194.11.1625","article-title":"Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.","volume":"194","author":"Klein","year":"2001","journal-title":"J Exp Med."},{"key":"2019111823182252100_B8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","article-title":"Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia.","volume":"194","author":"Rosenwald","year":"2001","journal-title":"J Exp Med."},{"key":"2019111823182252100_B9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/sonc.2002.32901","article-title":"Clinical translation of gene expression profiling in lymphomas and leukemias.","volume":"29","author":"Rosenwald","year":"2002","journal-title":"Semin Oncol."},{"key":"2019111823182252100_B10","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns.","volume":"95","author":"Eisen","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111823182252100_B11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.leu.2402107","article-title":"Differential expression of chemokine receptors in B cell malignancies.","volume":"15","author":"Du\u0308rig","year":"2001","journal-title":"Leukemia."},{"key":"2019111823182252100_B12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.leu.2402339","article-title":"CD38 expression is an important prognostic marker in chronic lymphocytic leukemia.","volume":"16","author":"Du\u0308rig","year":"2002","journal-title":"Leukemia."},{"key":"2019111823182252100_B13","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.","volume":"87","author":"Cheson","year":"1996","journal-title":"Blood."},{"key":"2019111823182252100_B14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V98.1.181","article-title":"CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.","volume":"98","author":"Ibrahim","year":"2001","journal-title":"Blood."},{"key":"2019111823182252100_B15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","article-title":"CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.","volume":"99","author":"Hamblin","year":"2002","journal-title":"Blood."},{"key":"2019111823182252100_B16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1046\/j.1365-2141.2001.03149.x","article-title":"Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.","volume":"115","author":"Jelinek","year":"2001","journal-title":"Br J Haematol."},{"key":"2019111823182252100_B17","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1182\/blood.V98.9.2633","article-title":"Clinical significance of CD38 expression in chronic lymphocytic leukemia.","volume":"98","author":"Del Poeta","year":"2001","journal-title":"Blood."},{"key":"2019111823182252100_B18","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2002-06-1683","article-title":"Expression of ZAP-70 is associated with increased B cell receptor signaling in chronic lymphocytic leukemia.","volume":"100","author":"Chen","year":"2002","journal-title":"Blood."},{"key":"2019111823182252100_B19","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1182\/blood.V99.7.2490","article-title":"Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells.","volume":"99","author":"Deaglio","year":"2002","journal-title":"Blood."},{"key":"2019111823182252100_B20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2249.2002.01787.x","article-title":"Adhesion to fibronectin via \u03b1 4 integrin (CD49d) protects B cells from apoptosis induced by serum deprivation but not via IgM or Fas\/Apo-1 receptors.","volume":"127","author":"Garcia-Gila","year":"2002","journal-title":"Clin Exp Immunol."},{"key":"2019111823182252100_B21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1189\/jlb.71.3.495","article-title":"Engagement of \u03b14\u03b21 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.","volume":"71","author":"De la Fuente","year":"2002","journal-title":"J Leukoc Biol."},{"key":"2019111823182252100_B22","first-page":"1331","article-title":"Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.","volume":"10","author":"Eksioglu-Demiralp","year":"1996","journal-title":"Leukemia."},{"key":"2019111823182252100_B23","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/1615-9861(200110)1:10<1191::AID-PROT1191>3.0.CO;2-8","article-title":"Translational control of the proteome: relevance to cancer.","volume":"1","author":"Dua","year":"2001","journal-title":"Proteomics."},{"key":"2019111823182252100_B24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1006\/excr.2000.4952","article-title":"Rapid up-regulation of peptide elongation factor EF-1\u03b1 protein levels is an immediate early event during oxidative stress-induced apoptosis.","volume":"259","author":"Chen","year":"2000","journal-title":"Exp Cell Res."},{"key":"2019111823182252100_B25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1006\/excr.1997.3819","article-title":"Apoptosis rate can be accelerated or decelerated by overexpression or reduction of the level of elongation factor-1 alpha.","volume":"238","author":"Duttaroy","year":"1998","journal-title":"Exp Cell Res."},{"key":"2019111823182252100_B26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0002-9440(10)65118-8","article-title":"Expression of the eukaryotic translation initiation factors 4E and 2\u03b1 in non-Hodgkin's lymphomas.","volume":"155","author":"Wang","year":"1999","journal-title":"Am J Pathol."},{"key":"2019111823182252100_B27","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1073\/pnas.96.12.6745","article-title":"Broad pattern of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays.","volume":"96","author":"Alon","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111823182252100_B28","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1073\/pnas.98.3.1176","article-title":"Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.","volume":"98","author":"Welsh","year":"2001","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/7\/2748\/1267474\/h80703002748.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/7\/2748\/1267474\/h80703002748.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T14:09:06Z","timestamp":1682431746000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/7\/2748\/106671\/Expression-of-ribosomal-and-translationassociated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,1]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,4,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-09-2683","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4,1]]}}}